share_log

MIMEDX to Host First Quarter 2024 Operating and Financial Results Conference Call on April 30

MIMEDX to Host First Quarter 2024 Operating and Financial Results Conference Call on April 30

MIMEDX將於4月30日舉辦2024年第一季度運營和財務業績電話會議
GlobeNewswire ·  04/16 20:00

MARIETTA, Ga., April 16, 2024 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) ("MIMEDX" or the "Company") today announced that it will report its operating and financial results for the first quarter ended March 31, 2024 after the market close on Tuesday, April 30, 2024. The MIMEDX senior management team will host a webcast and conference call to review its results beginning at 4:30 p.m. Eastern Time on the same day.

喬治亞州瑪麗埃塔,2024年4月16日(環球新聞專線)——MimedX集團公司(納斯達克股票代碼:MDXG)(“MIMEDX” 或 “公司”)今天宣佈,將在2024年4月30日星期二收盤後公佈截至2024年3月31日的第一季度的運營和財務業績。MIMEDX高級管理團隊將在美國東部時間當天下午 4:30 開始主持網絡直播和電話會議,審查其業績。

The conference call can be accessed using the following information:

可以使用以下信息訪問電話會議:

Webcast: Click here
U.S. Investors: 877-407-6184
International Investors: 201-389-0877
Conference ID: 13745475

網絡直播:點擊這裏
美國投資者:877-407-6184
國際投資者:201-389-0877
會議 ID:13745475

A replay of the webcast will be available for approximately 30 days on the Company's website at following the conclusion of the event.

活動結束後,將在公司網站上重播約30天的網絡直播。

About MIMEDX
MIMEDX is a pioneer and leader focused on helping humans heal. With more than a decade of helping clinicians manage chronic and other hard-to-heal wounds, MIMEDX is dedicated to providing a leading portfolio of products for applications in the wound care, burn, and surgical sectors of healthcare. The Company's vision is to be the leading global provider of healing solutions through relentless innovation to restore quality of life. For additional information, please visit .

關於 MIMEDX
MIMEDX 是專注於幫助人類康復的先驅和領導者。憑藉十多年來幫助臨床醫生管理慢性傷口和其他難以癒合的傷口,MIMEDX 致力於爲醫療保健的傷口護理、燒傷和外科領域的應用提供領先的產品組合。該公司的願景是通過不懈的創新來恢復生活質量,成爲全球領先的治療解決方案提供商。欲了解更多信息,請訪問 。

Contact:
Matt Notarianni
Investor Relations
470-304-7291
mnotarianni@mimedx.com

聯繫人:
馬特·諾塔裏安尼
投資者關係
470-304-7291
mnotarianni@mimedx.com


譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論